Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study

✍ Scribed by Mir Abolfazl Ostad; Silke Eggeling; Peter Tschentscher; Edzard Schwedhelm; Rainer Böger; Philip Wenzel; Thomas Meinertz; Thomas Munzel; Ascan Warnholtz

• Book ID: 118422383
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 163 KB
• Volume: 205
• Category: Article
• ISSN: 0021-9150
• DOI: 10.1016/j.atherosclerosis.2008.11.032